News and resources | Resources
Video 29 April 2015

Radio France Internationale – La lutte contre les faux médicaments

By IFPMA
Share
Topics
Falsified medicines

Click here to listen to the full interview

About IFPMA

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.

Learn more

Media Contact

Elliot Dunster

Related news and resources

Statement 5 Apr 2024

Enhanced collaboration between anti-doping agency and big pharma bolsters support for clean sport among athletes

On 3 April 2024 in Athens, the International Federationof Pharmaceutical Manufacturers and Associations (IFPMA) and the World Anti-Doping Agency (WADA) signed a joint letter of intent. 

Read more
Statement 1 Feb 2023

Substandard and falsified medical products (EB152)

On 1 February 2023, IPSF submitted a statement delivered on behalf of IPSF, IAPO, and IFPMA for the WHO EB152 agenda item related to substandard and falsified medical products.

Read more
Statement 10 Jun 2021

IFPMA and local pharmaceutical industry associations call on the African and global health communities to raise awareness about the dangers of substandard and falsified medical products

On World Anti-counterfeit day, 10 June 2021, the IFPMA hosted a joint event with local Pharmaceutical Industry Associations from across the African continent to tackle the topic of falsified medicines and chart a robust response to eliminate falsified medicines in the region.

Read more
Top